Analyzing Impact of Bisphosphonates on Breast Cancer Survival
Breast cancer (BC) often metastasizes to bone. Data are conflicting as to whether bisphosphonates may have anticancer properties when used in BC. There are currently six bisphosphonates on the market: alendronate, etidronate, ibandronate, pamidronate, risedronate, and zoledronic acid. Read more.
|
Does Cognitive Impairment Affect Treatment Choices in Older Women?
Cognitive impairment (CI) and dementia increase with older age. An estimated 7% to 10% of women with breast cancer (BC) have CI or dementia, and the all-cause mortality rate within 2 years of dementia diagnosis is sixfold higher than in cognitively intact adults. Patients with CI and cancer often present with more advanced disease, which can affect prognosis. Read more.
|